← Back to Search

Interoceptive exposure for Anxiety Sensitivity

Phase 2
Waitlist Available
Led By Brett Deacon, Ph.D.
Research Sponsored by University of Wyoming
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Score \> 21 on Anxiety Sensitivity Index - Revised Fear of Respiratory Symptoms Subscale.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week after the single-session intervention

Summary

This study compares the relative efficacy of three methods of delivering interoceptive exposure for the reduction of elevated anxiety sensitivity. The interventions vary according to their intensity and use of coping strategies during exposure. An expressive writing intervention serves as an expectancy control.

Eligible Conditions
  • Anxiety Sensitivity

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately following the single-session intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately following the single-session intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Fear of Anxiety-Related Body Sensations
Secondary study objectives
Beck Anxiety Inventory
Hypervigilance to anxiety-related body sensations
Peak Anxiety During a Symptom Induction Task

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Interoceptive exposureExperimental Treatment3 Interventions
Repeated trials of voluntary hyperventilation intended to reduce fears of arousal-related body sensations.
Group II: Expressive writingPlacebo Group1 Intervention
Expectancy control intervention.

Find a Location

Who is running the clinical trial?

University of WyomingLead Sponsor
17 Previous Clinical Trials
1,317 Total Patients Enrolled
Brett Deacon, Ph.D.Principal InvestigatorUniversity of Wyoming
~8 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top